| 111 |
HYPOALBUMINEMIA IMPLICATIONS ON ORGAN FAILURE AND IMMUNE FUNCTION AFTER MAJOR CANCER SURGERY
|
2017 |
| 112 |
HYPOALBUMINEMIA IMPLICATIONS ON ORGAN FAILURE AND IMMUNE FUNCTION AFTER MAJOR CANCER SURGERY
|
2017 |
| 113 |
HYPOALBUMINEMIA IMPLICATIONS ON ORGAN FAILURE AND IMMUNE FUNCTION AFTER MAJOR CANCER SURGERY
|
2017 |
| 114 |
HYPOALBUMINEMIA IMPLICATIONS ON ORGAN FAILURE AND IMMUNE FUNCTION AFTER MAJOR CANCER SURGERY
|
2017 |
| 115 |
HYPOALBUMINEMIA IMPLICATIONS ON ORGAN FAILURE AND IMMUNE FUNCTION AFTER MAJOR CANCER SURGERY
|
2017 |
| 116 |
HYPOALBUMINEMIA IMPLICATIONS ON ORGAN FAILURE AND IMMUNE FUNCTION AFTER MAJOR CANCER SURGERY
|
2017 |
| 117 |
HYPOALBUMINEMIA IMPLICATIONS ON ORGAN FAILURE AND IMMUNE FUNCTION AFTER MAJOR CANCER SURGERY
|
2017 |
| 118 |
HYPOALBUMINEMIA IMPLICATIONS ON ORGAN FAILURE AND IMMUNE FUNCTION AFTER MAJOR CANCER SURGERY
|
2017 |
| 119 |
Multidisciplinary Management of Spinal Chordoma: Single Institution Study |
2017 |
| 120 |
P-458 Pain Experience Profile in Children with Cancer: Prospective Analysis of 2216 Treatment Days in a Developing Country |
2017 |